Recalls and suspensions

Subscribe to TGA safety information
22 December 2021
Recall - Possible presence of benzene
16 December 2021
Device repair/replacement program - progress update
14 September 2021
Recall due to risk of bacterial contamination
2 August 2021
Recall - Possible presence of benzene

More safety information »

Safety information

Subscribe to TGA safety information
20 January 2022
Medicines Safety Update - Information for consumers
20 January 2022
Medicines Safety Update - Information for health professionals
20 January 2022
Acellur Dermal Matrix Products used in Breast Reconstruction - clarification on reports of potential higher complication rates.
20 January 2022
TGA's safety monitoring of COVID-19 vaccines.

More safety information »

News

Subscribe to TGA latest news and updates
27 January 2022
New information about importing self-tests and an updated consumer fact sheet.
25 January 2022
A further update by the TGA on the proposed reforms to medicinal cannabis, labelling and packaging requirements.
25 January 2022
The TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on options for the TGA's proposed fees and charges for the 2022-23 financial year. Closing date: 7 March 2022
25 January 2022
Australian Public Assessment Report for nirmatrelvir/ritonavir

More news »